You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 8, August 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neoplasms
 •Alert me on articles by topic

Melanoma

Lessons From Metastases

Arch Dermatol. 1998;134:1027-1028.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MELANOMA, a common and serious disease encountered by dermatologists, has several unique features. Three questions of concern to the dermatologist are as follows: First, what is the difference between radial and vertical growth melanoma in terms of biology? Second, why does the prognosis of melanoma significantly worsen when the lesion becomes greater than 0.75 mm in thickness? Finally, how can the phenomenon of metastasis years and even decades after initial resection be explained? The article by Barnhill et al1 teaches us some basic lessons about the behavior of melanoma, lessons that may be useful in answering these 3 questions about melanoma.

While increased rates of cell proliferation account for in vivo growth of tumors, the mechanisms by which tumors stop growing in animals have only recently been explained. Current evidence based on experiments in mice reveal that there are 2 reasons why tumors do not grow in vivo, or become . . . [Full Text of this Article]


RELATED ARTICLE

Tumor Vascularity, Proliferation, and Apoptosis in Human Melanoma Micrometastases and Macrometastases
Raymond L. Barnhill, Michael W. Piepkorn, Alistair J. Cochran, Evelyn Flynn, Themis Karaoli, and Judah Folkman
Arch Dermatol. 1998;134(8):991-994.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Interferon {alpha}2b Decreases Hepatic Micrometastasis in a Murine Model of Ocular Melanoma by Activation of Intrinsic Hepatic Natural Killer Cells
Yang et al.
IOVS 2004;45:2056-2064.
ABSTRACT | FULL TEXT  

The Zimmerman-McLean-Foster hypothesis: 25 years later
Singh et al.
Br. J. Ophthalmol. 2004;88:962-967.
ABSTRACT | FULL TEXT  

Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling
Govindarajan et al.
J. Biol. Chem. 2003;278:9790-9795.
ABSTRACT | FULL TEXT  

Mitogen-actived Protein Kinase Activation Is an Early Event in Melanoma Progression
Cohen et al.
Clin. Cancer Res. 2002;8:3728-3733.
ABSTRACT | FULL TEXT  

Biological Behavior of Human Breast Cancer Micrometastases
Klauber-DeMore et al.
Clin. Cancer Res. 2001;7:2434-2439.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.